REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
25/04/2026
Voltar para busca
Dado oficial do USPTO
REVERSE TRANSLATIONAL MEDICINE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
REVERSE TRANSLATIONAL MEDICINE
ST13
US500000085984179Classe
5, 42, 44
Pedido
85984179
Registro
5188931
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
102
Atualização mais recente
26/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
20/06/2012
Data de registro
25/04/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/06/2023
Última transação
26/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
99
Localização do titular
Schlieren, CH
Examinador
LEHKER, DAWN FELDMAN
Unidade examinadora
M20
Titulares e representantes
Titulares
Neurimmune Holding AG
Representantes
Janice Housey
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations to treat diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; veterinary preparations to treat diseases of the nervous systeminfectious diseasesneoplasmsdiseases of the immune systemendocrine and metabolic diseasesdiseases of the circulatory systemdiseases of the eye; pharmaceutical preparations for immunotherapy; pharmaceutical preparations for use as tumor suppressing agents; pharmaceutical preparations to treat neurodegenerative diseases; pharmaceutical preparations for use in immunogenics; vaccines; diagnostic kits consisting primarily of monoclonal antibodiesbuffers and reagents for use in disease testing; Biological preparations in the nature of antibodies targeting specific epitopes of proteins for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases; synthetic peptides for use in the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; biological preparations for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfections; diagnostic preparations for medical and veterinary use; Dietetic foodgluten-free foodlow-sodium foodlow-calorie or reduced calorie food for weight reduction adapted for medical purposesdietetic bread and dietetic noodles; dietetic beveragesgluten-free beverageslow-sodium beveragesdietetic tea; Low calorie or reduced-calorie beverages for weight reduction adapted for medical purposeslow calorie or reduced calorie fruit beverages; Protein antibodies sold as an ingredient of pharmaceuticals for the treatment of diseases of the CNSmetabolic diseasescardiovascular diseasescancerpsychiatric diseasesinfectionsimmunologic diseasesinflammatory diseasesrespiratory diseasespsychological diseases
Classe 42
Testinginspection or research of pharmaceuticalscosmetics or foodstuffs; Consultation and providing information about testinginspection or research of pharmaceuticalscosmetics or foodstuffs; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research in the field of biotechnology and antibodies; providing scientific information of testinginspection or research of medical treatment and technique; scientific research about health care; biology research ; computer hardware design and development; computer software design and development
Classe 44
Medical services; medical services in the field of immunity; providing medical information; physical examination for medical purposes; preparation and dispensing of medications; dietary and nutritional guidance; consultancy and providing information of health care; veterinary services; beauty salons; animal grooming; health care; Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Publicações
Histórico de despachos e eventos da marca no USPTO.
102 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/05/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/05/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/05/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
15/06/2023
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
15/06/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/06/2023
E815
TEAS SECTION 8 & 15 RECEIVED
15/12/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
25/04/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/01/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/01/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/01/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
21/01/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/07/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
21/07/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/07/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/07/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
25/04/2017
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
17/03/2017
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/12/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/11/2016
PUBO
PUBLISHED FOR OPPOSITION
01/11/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/10/2016
IUCN
NOTICE OF ALLOWANCE CANCELLED
28/09/2016
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
04/08/2016
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
04/08/2016
DPCC
DIVISIONAL PROCESSING COMPLETE
13/07/2016
APET
ASSIGNED TO PETITION STAFF
08/07/2016
DRRR
DIVISIONAL REQUEST RECEIVED
22/06/2016
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
22/06/2016
UNTD
REQUEST TO DIVIDE UNTIMELY, REFUSED, OR WITHDRAWN
10/06/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/06/2016
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
26/04/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
23/04/2016
EX4G
SOU EXTENSION 4 GRANTED
22/04/2016
EXT4
SOU EXTENSION 4 FILED
21/04/2016
EEXT
SOU TEAS EXTENSION RECEIVED
21/04/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/03/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/10/2015
EX3G
SOU EXTENSION 3 GRANTED
15/10/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
14/10/2015
EXT3
SOU EXTENSION 3 FILED
07/10/2015
EEXT
SOU TEAS EXTENSION RECEIVED
07/10/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
19/05/2015
EX2G
SOU EXTENSION 2 GRANTED
16/05/2015
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
16/05/2015
EXT2
SOU EXTENSION 2 FILED
15/04/2015
EEXT
SOU TEAS EXTENSION RECEIVED
15/04/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/06/2014
EX1G
SOU EXTENSION 1 GRANTED
13/06/2014
EXT1
SOU EXTENSION 1 FILED
13/06/2014
EEXT
SOU TEAS EXTENSION RECEIVED
13/06/2014
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/05/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/03/2014
PUBO
PUBLISHED FOR OPPOSITION
11/03/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/02/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/02/2014
ALIE
ASSIGNED TO LIE
05/02/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/02/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
05/02/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/02/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
05/02/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/02/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/11/2013
GNRT
NON-FINAL ACTION E-MAILED
04/11/2013
CNRT
NON-FINAL ACTION WRITTEN
04/11/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
25/10/2013
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
20/10/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/10/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
07/10/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/10/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
07/10/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/10/2013
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/10/2013
ALIE
ASSIGNED TO LIE
28/09/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/09/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/09/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/09/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/09/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/03/2013
GNRT
NON-FINAL ACTION E-MAILED
22/03/2013
CNRT
NON-FINAL ACTION WRITTEN
22/03/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/02/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2013
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/10/2012
GNRT
NON-FINAL ACTION E-MAILED
16/10/2012
CNRT
NON-FINAL ACTION WRITTEN
16/10/2012
DOCK
ASSIGNED TO EXAMINER
05/10/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/06/2012
NWAP
NEW APPLICATION ENTERED
23/06/2012
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace REVERSE TRANSLATIONAL MEDICINE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.